KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Change in Accured Expenses (2016 - 2017)

Palvella Therapeutics (PVLA) has disclosed Change in Accured Expenses for 6 consecutive years, with -$358000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Change in Accured Expenses changed N/A to -$358000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1.0 million, a N/A change, with the full-year FY2024 number at $1.0 million, up 189.21% from a year prior.
  • Change in Accured Expenses was -$358000.0 for Q4 2024 at Palvella Therapeutics, down from $383000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $739000.0 in Q2 2024 to a low of -$358000.0 in Q4 2024.